Dossier · BBAR · Dormant
BBAR · Banco BBVA Argentina S.A. · Stock research
Last analysed ·
Current thesis
Argentina country trade re-accelerated: June CPI printed 1.9% MoM on 2026-07-14 (first sub-2% of the cycle) and country risk broke to 402bp, tightest since April 2018, carrying BBAR to a fresh 52-week high of $22.47. Price now sits above every published target while Q1 ROE was 8.3% — the macro is leading, the bank is lagging.
Invalidation trigger
A weekly close below $18.00 negates the July breakout above the $21.38 prior high and puts the ADR back inside the June range; secondary confirmation: Argentine country risk widening back through 500bp, or INDEC monthly CPI re-accelerating above 2.5% MoM for two consecutive prints.
Thesis status
Open commitment catalyst in 15dscored if the trigger above fires How this is scored →Latest analysis and events for BBAR —
As of 2026-07-19, orbyd's latest analysis for Banco BBVA Argentina S.A. (BBAR): Note of 2026-07-17: Merval -3.22% to 3,185,257 on heavy profit-taking, GGAL -4.1% on $12m turnover. First real distribution day of the July leg — watch whether it resolves as a shelf or a top.
Invalidation trigger: A weekly close below $18.00 negates the July breakout above the $21.38 prior high and puts the ADR back inside the June range; secondary confirmation: Argentine country risk widening back through 500bp, or INDEC monthly CPI re-accelerating above 2.5% MoM for two consecutive prints.
Next dated event on file: — catalyst in 15d.
Current Thesis
The Argentina reflation trade did not roll over in July — it made a new high. BBAR tagged $22.47 in mid-July, clearing the $21.38 level that had capped it since the post-midterm parabola, and traded $20.71 on 2026-07-15. Two things fired in the same week: INDEC's June CPI came in at 1.9% MoM on 2026-07-14, the first sub-2% monthly print of the cycle, and Argentine country risk compressed to 402 basis points, the tightest since April 2018. That combination is what the whole thesis was waiting for — disinflation and a sovereign re-rating arriving together — and a 12%-share bank levered to peso credit volumes is the high-beta way to own it.
What keeps this from being a fat pitch is the gap between the macro and the enterprise. Q1 2026 ROE was 8.3%. Management cut FY2026 real loan-growth guidance to 15-20% from 25-30%. The ADR now trades above every published sell-side target, UBS having moved to $20 with a Neutral rating on 2026-07-10 — and price went straight through it. The peso, meanwhile, sits at 1,476-1,487 per dollar, within a fraction of a percent of its 52-week weak extreme, so the sovereign is re-rating while the currency does not. Buyers here are underwriting the country's balance sheet, and getting the bank's earnings power as a call option that has not yet been exercised.
Bullish and bearish views on Banco BBVA Argentina S.A.
The model's bull view on Banco BBVA Argentina S.A. (BBAR), in brief: Disinflation re-accelerated: June 2026 CPI +1.9% MoM (INDEC, published 2026-07-14), the first sub-2% print, with core at 1.6% and H1 accumulated inflation of 16.8%. The bear view: The bank is not earning its cost of equity. Both cases follow in full.
Bull Case
- Disinflation re-accelerated: June 2026 CPI +1.9% MoM (INDEC, published 2026-07-14), the first sub-2% print, with core at 1.6% and H1 accumulated inflation of 16.8%. That trajectory tracks the optimistic end of the widely dispersed 2026 forecast band (IMF 16.4% / BBVA 22% / JPM 26% / OECD ~30%).
- Sovereign credit re-rating is the dominant driver and it is working: country risk at 402bp in early July and pinned near 406bp on 2026-07-17 — an eight-year low. Cheaper sovereign financing flows directly into every Argentine borrower's cost of funds.
- Reserve accumulation beat the calendar: the BCRA had purchased US$10.1bn by late June 2026, clearing its full-year US$10bn target in roughly six months, with the IMF net-reserve goal roughly 70% met with more than half the year remaining.
- Funding risk largely defused: Caputo's 2026-2027 plan covers ~US$19bn of repayments with refinancing over-fulfilled by US$3.7bn — US$800m from privatisations, a US$1.9bn IMF disbursement, ~US$6bn of domestic issuance.
- Cluster confirmation is unambiguous: on the early-July leg, GGAL, BMA and CEPU ADRs moved 5.8-9% together, with Galicia the most-traded name on both NYSE and BYMA. The basket breaks out as a unit, which is exactly what a country-level narrative looks like.
- Share gain ahead of the volume cycle: loan market share reached 12.15% in Q1 2026, +95bps YoY, on an 18.8% regulatory capital ratio — capacity to fund expansion is not the constraint.
- Earnings direction still positive: Q1 2026 (2026-05-26) inflation-adjusted net income ARS 85.2B, +31.2% QoQ; NII ARS 879.9B, +5.9% QoQ; NIM 18.6% as funding costs fell faster than asset yields. EPS $0.27 against a $0.17 estimate.
Bear Case
- The bank is not earning its cost of equity. 8.3% ROE in Q1 2026 does not compound book value at a rate that justifies a re-rating on fundamentals; the entire move is multiple expansion driven by country risk.
- Guidance moved the wrong way. FY2026 real loan growth was cut to 15-20% from 25-30% on the 2026-05-26 call, and loan-volume acceleration is the thesis. Peso loans fell 6.5% QoQ in Q1; the growth came from FX lending (+6.8% QoQ, +23.3% in USD), which carries devaluation exposure if the managed band breaks.
- The currency is not confirming. At 1,476-1,487 per dollar the peso sits at the weak edge of its band while sovereign spreads collapse. For a dollar-denominated ADR, peso weakness is a direct tax on translated earnings — the divergence resolves one way or the other.
- Valuation has no anchor left. Price cleared UBS's freshly raised $20 target within days of the 2026-07-10 revision, and GuruFocus marks the stock 207.7% above its $6.73 GF Value. When price leads every published estimate, the marginal buyer is momentum, not analysis.
- First real distribution appeared 2026-07-17: the Merval fell 3.22% to 3,185,257 on heavy profit-taking with GGAL down 4.1% on $12m of turnover. One session is not a top, but the index is now ~6% off its 52-week high after a near-vertical multi-week run.
- The story is public. Mainstream turnaround coverage started with Benzinga's 7-stocks piece on 2026-06-12; the easy asymmetry belonged to whoever owned it before the October 2025 midterm gap.
- Monetary-framework fragility remains the tail risk. A reserve shortfall, a band adjustment, or re-imposition of FX controls would hit the whole basket simultaneously and without warning.
Setup & Price Structure
The 52-week range is $7.76 to $22.47 — a 2.9x from the low, with the October 2025 midterm result producing a +40.75% single session to a $14.23 close. The structure that matters now is the July breakout: after roughly two months of consolidation capped by the $21.38 prior high, price cleared it into the 2026-07-14 CPI print and the country-risk break to 402bp, then pulled back to the $20-21 area by mid-month. That leaves an untested breakout shelf in the $19-20 zone and a deeper structural floor around $18, which was the top of the June range.
The name is extended but not blown off. It is a country trade in the middle of a sovereign re-rating, and re-ratings of this type run further than any single-name valuation frame suggests — Argentine spreads went from crisis pricing to 2018 tights in nine months and have room to 300bp if the reserve path holds. The honest counter is that the 2026-07-17 session was the first time the basket sold off hard on volume since the leg began, and a second such day would turn the July high into a distribution shelf rather than a launch pad.
Position sizing should reflect that this is one exposure, not several. BBAR, GGAL, BMA, SUPV, YPF, PAM, CEPU and ARGT are a single correlated bet on the same policy trajectory; owning three of them is one position at triple weight.
Catalyst Calendar (next 30 days)
- ~2026-08-13 (est.) — INDEC July national CPI. The key read: does the sub-2% June print (1.9% MoM) hold, or was seasonal drag flattering it? Two consecutive prints above 2.5% MoM would break the disinflation narrative outright.
- Ongoing, daily — Argentine country risk. Currently 402-406bp. A sustained move below 400bp is fresh confirmation; widening through 500bp signals the sovereign leg is unwinding.
- Late July / early August (est.) — BCRA monthly reserve data. The bank has already cleared its US$10bn purchase target; the market now watches the net-reserve path toward the US$8bn full-year IMF goal, currently ~70% met.
- Ongoing — peso fix within the managed band, currently 1,476-1,487 per dollar. Any band widening or step adjustment is a basket-wide event.
- 2026-08-24, after market — Q2 2026 results. Just outside the 30-day window but close enough to govern sizing decisions taken in August. The specific line to watch is ROE: the gap between 8.3% and the mid-teens is the difference between a macro trade and a franchise re-rating.
What Would Change Our Mind
Thesis break is defined at the price level first. A weekly close below $18.00 gives back the entire July breakout and puts the ADR back inside the June range — Above that level, high RSI, mainstream coverage, and price trading through published targets are all consistent with a country in the middle of a re-rating and are not by themselves reasons to stand aside.
Secondary conditions that would independently break the read: Argentine country risk widening back through 500bp; two consecutive INDEC monthly CPI prints above 2.5% MoM; re-imposition of FX or capital controls; withdrawal or non-renewal of the US$20bn US currency-swap line; or a Q2 print on 2026-08-24 that shows ROE stalled near 8% with real loan growth tracking below the already-cut 15-20% guide. A fresh entry taken in the three sessions before that print is a coin flip on a binary, not an expression of the macro thesis.
Correlation Notes
- The Argentina basket is one trade. GGAL, BMA, SUPV, CEPU, YPF, PAM, TGS, TEO and ARGT trade off the same three inputs: sovereign spreads (GD30/GD35), the peso/blue-chip swap, and MERVAL risk appetite. The 2026-07-17 session — Merval -3.22%, GGAL -4.1% — showed the correlation runs on the downside too.
- Bank execution is a second-order input. BBAR's Q1 EPS beat coincided with a sales miss ($620.3M vs $730.3M) and the stock closed +7.42% anyway; the tape was reading the country, not the income statement.
- Broad EM risk is the outer wrapper. Argentine assets are the highest-beta expression of EM risk appetite. A dollar-strength regime or a broad EM credit widening drags this basket regardless of domestic policy execution.
- The peso is the internal hedge that is not working. Country risk at eight-year tights alongside a peso at its 52-week weak extreme is an unusual configuration; historically these converge, and which one moves determines whether ADR holders keep the gain.
- US policy exposure is real but indirect. The US$20bn swap line is a political instrument as much as a financial one, which makes US-Argentina relations a live variable in the position.
Notes
- Q1 2026 reported 2026-05-27: inflation-adj net income ARS 85.2B (+31.2% QoQ), NIM 18.6%, ROE only 8.3%, efficiency 51.4%, capital ratio 18.8%, loan share 12.15% (+95bps YoY). FY2026 real loan-growth guide CUT to 15-20% from 25-30%.
- Q2 2026 earnings ~late Aug 2026 = next hard binary / blackout for sizing.
- Pure country-macro trade: peso/blue-chip-swap, sovereign spreads (GD30/GD35), MERVAL and EM risk drive it more than bank execution. Treat all Argentina ADR exposure (BMA/GGAL/SUPV/ARGT) as one correlated book.
- Mainstream turnaround coverage (Benzinga 7-stocks, 2026-06-12) = narrative going public; watch for theme tipping ACCELERATING -> MATURING.
- Oct-2025 midterm landslide (+40.75% day, close $14.23) was the political binary and it already fired.
- Pure country-macro trade: driven by the peso/blue-chip swap, sovereign spreads (GD30/GD35), country risk, MERVAL and EM risk appetite more than by bank execution. Treat all Argentina ADR exposure (GGAL/BMA/SUPV/YPF/PAM/ARGT) as one correlated book.
- Q1 2026 (reported 2026-05-26): inflation-adj net income ARS 85.2B (+31.2% QoQ), NIM 18.6%, ROE only 8.3%, efficiency 51.4%, capital ratio 18.8%, loan share 12.15% (+95bps YoY); EPS $0.27 beat $0.17 but sales $620.3M missed $730.3M. FY2026 real loan-growth guide CUT to 15-20% from 25-30%.
- Q2 2026 earnings after-market 2026-08-24 = next hard company binary / sizing blackout.
- Next macro binary: INDEC June national CPI ~2026-07-14 (May printed 33.6% YoY / 2.1% MoM on 2026-06-11). Watch for monthly re-acceleration >2.5% and BCRA reserves vs the IMF $4bn net-reserve path.
- Mainstream turnaround coverage (Benzinga 7-stocks, 2026-06-12) = narrative gone public; theme maturing off the post-Oct-2025-midterm parabola. 2026 inflation forecasts widely dispersed (IMF 16.4% / BBVA 22% / JPM 26% / OECD ~30%).
- $20bn US currency-swap line (Oct 2025) is a peso backstop and basket floor; its withdrawal or non-renewal would be a basket-wide negative.
- Price refresh 2026-07-04: $18.44, ~14% off the $21.38 52-wk high; 52-wk range $7.76-$21.38.
- Q2 2026 earnings after-market 2026-08-24 — hard company binary, avoid fresh sizing into the print.
- Next macro binary: INDEC July national CPI ~2026-08-13. June printed 1.9% MoM / 33.5% YoY / core 1.6%; H1 2026 accumulated 16.8%.
- Pure country-macro expression. Peso/blue-chip swap, sovereign spreads (GD30/GD35), country risk, MERVAL and EM risk appetite drive the ADR far more than bank execution. Treat all Argentina ADR exposure (GGAL/BMA/SUPV/YPF/PAM/CEPU/ARGT) as ONE correlated book — the July move was basket-wide, not idiosyncratic.
- Q1 2026 (reported 2026-05-26): inflation-adj net income ARS 85.2B (+31.2% QoQ), NII ARS 879.9B (+5.9% QoQ), NIM 18.6%, ROE only 8.3%, efficiency 51.4%, capital ratio 18.8%, loan share 12.15% (+95bps YoY). EPS $0.27 beat $0.17 but sales $620.3M missed $730.3M. FY2026 real loan-growth guide CUT to 15-20% from 25-30%.
- Divergence to monitor: country risk at 8-year tights (402-406bp) while the peso sits within ~0.3% of its 52-week weak extreme (1,476-1,487/USD). Credit is re-rating without currency strength — every peso of book earnings translates into fewer ADR dollars.
- Price is above published sell-side. UBS Neutral, PT raised $18 -> $20 on 2026-07-10; the ADR traded $20.71 on 2026-07-15 and tagged $22.47 intraday. GuruFocus GF Value $6.73 = price 207.7% above.
- 2026-07-17: Merval -3.22% to 3,185,257 on heavy profit-taking, GGAL -4.1% on $12m turnover. First real distribution day of the July leg — watch whether it resolves as a shelf or a top.
- $20bn US currency-swap line (Oct 2025) remains the peso backstop and basket floor. Non-renewal or withdrawal is a basket-wide negative.
- Oct-2025 midterm landslide (+40.75% single-day, close $14.23) was the political binary and it already fired. 52-week range $7.76-$22.47.
Related · shared themes
SE
Sea Limited
Three-engine re-acceleration — Shopee GMV +30%, Monee loan book +71%, Garena's best quarter in 5 years — drove a Q1 beat (2026-05-12) and a +19% one-month recovery off the $77 low. Fundamentally accelerating, but the stock is short-term extended above the July 1 Bollinger break and still ~48% under its $199 high, with the Q2 print (~Aug 11) as the next binary.
UGP
Ultrapar Participacoes S.A.
Brazilian fuel-distribution margin re-rate (tax-evasion crackdown) plus a live Ipiranga sale process (~R$25-30B; TotalEnergies/Aramco/J&F, BTG advising) is the leg; Q1 net income +151% YoY, sell-side confirming late (B of A upgrade 2026-07-08) into fresh 52-wk highs. 2026-08-12 Q2 print is the next test — momentum firm but PT headroom thin at $6.25 vs $6.50-7.40 targets.
BAK
Braskem S.A.
Parent-level distress in the courts: ~2026-06-26 60-day São Paulo shield plus Chapter 15 in SDNY, Fitch C / S&P default (2026-06-30); management skipping ~$177M July–Aug coupons and pushing an extrajudicial plan (5-yr extension, 100% PIK) that creditors rejected while demanding shareholder burden-sharing. ADR ~$2.47 near 52-wk lows, Street PT ~$1.50, live equity-impairment tail. No momentum leg — a distressed avoid.
BMA
Banco Macro S.A.
Argentina disinflation/credit-recovery basket; BMA is the best-capitalized domestic vehicle. Sequential CPI is genuinely improving (3.4%→2.6%→2.1%→1.9% MoM, Mar–Jun 2026), but the tape has gone nowhere since the Oct-2025 midterm leg — ~$90 vs the $106.15 high, four months mid-range. Cost of risk guided 5.5–6% caps near-term ROE; no company catalyst until the 2026-08-26 Q2 print, so the mid-August CPI release is the only near-term thesis mover.